Evolution of the Average Target: Cerence Inc.

Evolution of the Target Price: Cerence Inc.

Changes in Analyst Recommendations: Cerence Inc.

2a3.QlZhLVcE9oMFE8f_nxtHKDCOGCVn4ha5MHmo3GeLKCw.CnsXHi1CwfRNQJO472IVXWnmbkMzsVHPWEyFj1TmWlR6PypOI3aVzG1YpA~0602ade1ea0b88309af104ac245b4a32
04-02 Cantor Fitzgerald Initiates Cerence at Overweight With $11 Price Target MT
25-08-06 Cerence Q3 revenue beats expectations RE
25-01-22 Needham Upgrades Cerence to Buy From Hold, $16 Price Target MT
24-07-15 Evercore ISI Adjusts Cerence's Price Target to $5 From $8, Maintains In Line Rating MT
24-07-12 Baird Adjusts Price Target on Cerence to $6 From $8, Maintains Neutral Rating MT
24-05-10 Baird Adjusts Cerence Price Target to $8 From $15, Maintains Neutral Rating MT
24-05-10 Wedbush Adjusts Cerence's Price Target to $9 From $21, Keeps Neutral Rating MT
24-05-10 Wells Fargo Downgrades Cerence to Equalweight From Overweight, Price Target at $6.50 MT
24-04-17 Baird Adjusts Price Target on Cerence to $15 From $17, Maintains Neutral Rating MT
24-02-07 Wedbush Raises Cerence's Price Target to $21 From $19 After Higher-Than-Expected Fiscal Q1 Results, Keeps Neutral Rating MT
24-02-07 Craig-Hallum Downgrades Cerence to Hold From Buy, Price Target is $22 MT
23-11-29 Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Lower Outlook; Maintains Neutral Rating MT
23-11-29 Goldman Sachs Cuts Price Target on Cerence to $19 From $28 Amid Cut to Multi-Year Outlook, Lower Peer Multiples; Neutral Rating Kept MT
23-11-28 Wells Fargo Cuts Cerence's Price Target to $25 From $32, Maintains Overweight Rating MT
23-11-28 Needham Adjusts Cerence's Price Target to $23 From $34, Keeps Buy Rating MT
23-11-28 Wedbush Cuts Cerence's PT to $19 From $31 on Lower Multiple, Says Large Legacy Contract Write-Down to Overshadow Fiscal Year 2024 Guidance; Keeps Neutral Rating MT
23-08-09 Wedbush Raises Cerence's Price Target to $31 From $26 After Higher-Than-Expected Fiscal Q3 Results, Keeps Neutral Rating MT
23-05-11 Wedbush Cuts Cerence's Price Target to $26 From $32, Keeps Neutral Rating MT
23-05-10 Goldman Sachs Adjusts Price Target on Cerence to $28 From $31, Maintains Neutral Rating MT
23-02-10 Wedbush Raises Cerence's Price Target to $32 From $25 After Above-Street Fiscal Q1 Results, Keeps Neutral Rating MT
23-02-09 Goldman Sachs Adjusts Price Target on Cerence to $31 From $19, Maintains Neutral Rating MT
23-02-09 Baird Adjusts Price Target on Cerence to $30 From $23, Maintains Neutral Rating MT
23-02-09 Wells Fargo Adjusts Price Target on Cerence to $32 From $25, Maintains Overweight Rating MT
23-02-09 Needham Adjusts Cerence's Price Target to $42 From $40, Keeps Buy Rating MT
23-02-09 Craig-Hallum Upgrades Cerence to Buy From Hold, Price Target is $40 MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+8.04%
+41.28%
+41.1%
+9.99%
+0.06%
+21.68%
+1.28%
+70.42%
+32.62%
-5.62%
Average +22.08%
Weighted average by Cap. +37.75%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
10.80USD
Average target price
10.75USD
Spread / Average Target
-0.46%
High Price Target
12.00USD
Spread / Highest target
+11.11%
Low Price Target
9.000USD
Spread / Lowest Target
-16.67%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Cantor Fitzgerald
Needham & Co.
Wells Fargo Securities
Wedbush
Baird
Craig-Hallum
Goldman Sachs
Jefferies & Co.
Cowen
RBC Capital Markets
Berenberg Bank
Raymond James
Evercore ISI
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
10.80USD
Average target price
10.75USD
Spread / Average Target
-0.46%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CRNC Stock
  4. Consensus Cerence Inc.
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!